| Implementation of Lean and Six Sigma quality initiatives in hospitals: A goal theoretic perspective JR Langabeer, JL DelliFraine, J Heineke, I Abbass Operations Management Research 2, 13-27, 2009 | 177 | 2009 |
| Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy CC Wykoff, RN Khurana, QD Nguyen, SP Kelly, F Lum, R Hall, IM Abbass, ... Diabetes care 44 (3), 748-756, 2021 | 96 | 2021 |
| Predictors of all-cause 30 day readmission among Medicare patients with type 2 diabetes J Collins, IM Abbass, R Harvey, B Suehs, C Uribe, J Bouchard, T Prewitt, ... Current medical research and opinion 33 (8), 1517-1523, 2017 | 55 | 2017 |
| Five-year patterns of diabetic retinopathy progression in US clinical practice A Moshfeghi, V Garmo, D Sheinson, A Ghanekar, I Abbass Clinical Ophthalmology, 3651-3659, 2020 | 26 | 2020 |
| Medication nonadherence: the role of cost, community, and individual factors I Abbass, L Revere, J Mitchell, A Appari Health services research 52 (4), 1511-1533, 2017 | 26 | 2017 |
| Impact of electronic health records on nurses’ productivity I Abbass, J Helton, S Mhatre, SS Sansgiry CIN: Computers, Informatics, Nursing 30 (5), 237-241, 2012 | 26 | 2012 |
| Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin M Datar, C Crivera, H Rozjabek, IM Abbass, Y Xu, MK Pasquale, ... American Journal of Health-System Pharmacy 76 (5), 275-285, 2019 | 24 | 2019 |
| Work productivity outcomes associated with ocrelizumab compared with other disease-modifying therapies for multiple sclerosis EE Neuberger, IM Abbass, E Jones, NJ Engmann Neurology and Therapy 10, 183-196, 2021 | 18 | 2021 |
| Real-World persistence with tocilizumab compared to other subcutaneous biologic disease-modifying antirheumatic drugs among patients with rheumatoid arthritis switching from … JH Best, SC Vlad, L Tominna, I Abbass Rheumatology and Therapy 7, 345-355, 2020 | 18 | 2020 |
| Revisiting the Economic Efficiencies of Observation Units MI Abbass, MT Krause, SS Virani, MJ Swint, W Chan, L Franzini Managed Care 24 (3), 46-52, 2015 | 15 | 2015 |
| Houston Hospitals Emergency Department Use Study C Begley, P Courtney, I Abbass, N Ahmed, K Burau https://sph.uth.edu/content/uploads/2013/06/Final2011ER.pdf, 2013 | 13 | 2013 |
| Impact of overactive bladder step therapy policies on medication utilization and expenditures among treated Medicare members IM Abbass, EO Caplan, DB Ng, R Kristy, CR Schermer, P Bradt, ... Journal of Managed Care & Specialty Pharmacy 23 (1), 27-37, 2017 | 9 | 2017 |
| One‐year outcomes associated with using observation services in triaging patients with nonspecific chest pain IM Abbass, SS Virani, J Michael Swint, W Chan, L Franzini Clinical Cardiology 37 (10), 591-596, 2014 | 9 | 2014 |
| Impact of coexisting overactive bladder in Medicare patients with osteoporosis EO Caplan, IM Abbass, BT Suehs, DB Ng, K Gooch, C Kirby, P Abbott Archives of gerontology and geriatrics 75, 44-50, 2018 | 7 | 2018 |
| Variability in the initial costs of care and one-year outcomes of observation services I Abbass Western Journal of Emergency Medicine 16 (3), 395, 2015 | 7 | 2015 |
| Healthcare resource use and burden associated with influenza transmission among household members with a primary infection: commercial claims data analysis C Wallick, IM Abbass, D Sheinson, D Moawad ClinicoEconomics and Outcomes Research, 335-342, 2021 | 6 | 2021 |
| Healthcare costs of potential glucocorticoid-associated adverse events in patients with giant cell arteritis JH Best, AM Kong, DM Smith, I Abbass, M Michalska ClinicoEconomics and Outcomes Research, 799-807, 2019 | 6 | 2019 |
| Impact of coexisting overactive bladder in medicare patients with dementia on clinical and economic outcomes EO Caplan, IM Abbass, BT Suehs, DB Ng, K Gooch, D van Amerongen American Journal of Alzheimer's Disease & Other Dementias® 34 (7-8), 492-499, 2019 | 6 | 2019 |
| Trends in healthcare resource use preceding diagnosis of Alzheimer’s disease dementia IM Abbass, D Choi, C Wallick, SS Assunção International Journal of Alzheimer’s Disease 2023 (1), 8154701, 2023 | 5 | 2023 |
| Healthcare resource utilization and costs in individuals with Huntington’s disease by disease stage in a US population A Exuzides, TM To, IM Abbass, JT Ta, AM Patel, A Surinach, RLM Fuller, ... Journal of Medical Economics 25 (1), 722-729, 2022 | 4 | 2022 |
